IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Wildcat Capital Management, LLC

Q3 2024 Holdings

Filed 2024-11-08 | 7 holdings | $204.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Frontier Group Hldgs Inc(ULCC)COM35909R108$150.1M28,061,35173.4%
RLX Technology Inc(RLX)SPONSORED ADS74969N103$32.7M18,046,19516.0%
Allogene Therapeutics Inc(ALLO)COM019770106$8.2M2,920,7874.0%
Urogen Pharma LTD(URGN)COMM96088105$6.3M495,6063.1%
Skillz IncCOM83067L109$5.5M979,8482.7%
Kronos BIO Inc(KRON1USD)COM50107A104$1.3M1,297,9590.6%
Silexion Therapeutics CorpSHSG1281K106$535.9K1,020,8520.3%